Beacon Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658K Sell
5,120
-1
-0% -$117 0.21% 101
2026
Q1
$616K Buy
5,121
+1
+0% +$115 0.23% 94
2025
Q4
$539K Hold
5,120
0.22% 98
2025
Q3
$430K Buy
5,120
+2
+0% +$165 0.18% 113
2025
Q2
$405K Buy
5,118
+2
+0% +$159 0.17% 115
2025
Q1
$459K Buy
5,116
+3
+0.1% +$280 0.22% 105
2024
Q4
$509K Buy
+5,113
New +$527K 0.24% 101

Other funds holding MRK

Beacon Investment Advisors's MRK Position: Q2 2026 in Review

Beacon Investment Advisors reduced its Merck (MRK) stake by 0.02% in Q2 2026, selling an estimated $117 and leaving 5,120 shares worth $658K. The position accounts for 0.21% of the portfolio, ranked #101.

Beacon Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Beacon Investment Advisors held 5,120 shares of Merck worth $658K as of Q2 2026.
  • Beacon Investment Advisors sold 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.21% of Beacon Investment Advisors's portfolio in Q2 2026, its #101 holding.
  • Beacon Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Beacon Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.